Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/20791
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Antibodies, Monoclonal/adverse effects/*therapeutic use,Antirheumatic Agents/adverse effects/*therapeutic use,Arthritis, Rheumatoid/*drug therapy,Drug Hypersensitivity/etiology,Drug Therapy, Combination,Female,Humans,Infection/chemically induced,Male,Methotrexate/administration & dosage,Middle Aged,Patient Compliance,Proportional Hazards Models
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/20791
ISSN: 0002-9343
Link: http://www.ncbi.nlm.nih.gov/pubmed/15866254
http://ac.els-cdn.com/S0002934305000720/1-s2.0-S0002934305000720-main.pdf?_tid=a675175e8b7616e934bf6a420b45d6f8&acdnat=1333526864_fb436601d6310f8d094f575a51d5bca9
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Voulgari-2005-Infliximab therapy i.pdf129.06 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons